IPKat: Ruling in Generics (t/a Mylan) v Yeda and Teva

Today’s ruling by Mr Justice Arnold (Patents Court, England and Wales) in Generics (t/a Mylan) v Yeda and Teva has been summarised by Darren Smyth for the IPKat.

The case relates to a European patent owned by Yeda (for which Teva is exclusive licensee) for Teva’s glatiramer acetate product marketed under the trademark Copaxone.

Patentability of computer programs - High Court judgment gives rise to useful examples of a “technical effect”

(HTC Europe Co Ltd v Apple Inc [2012] EWHC 1789). A further decision in the so-called “smartphone wars” was issued by the High Court recently in relation to a patent dispute between HTC Europe Co Ltd (‘HTC’) and Apple Inc (‘Apple’). In total, fo...

EIP attend launch of London Cleantech Cluster

EIP joined more than 100 attendees at the official launch of the London Cleantech Cluster (LCC) on 18 July. The LCC intends to coordinate programmes and support cleantech businesses across the capital and in the London region. Founding supporters incl...

Associate Sunny Bansal qualifies as European Patent Attorney

Associate Sunny Bansal has qualified as a European Patent Attorney after passing his remaining papers in the European Qualifying Examinations for patent attorneys. Computer software and telecommunications specialist Sunny passed EQE papers C and D. Al...

Samsung victorious in dispute with Apple over tablet computers

Samsung has won a longstanding battle with Apple concerning one of Apple's Registered Community Designs for its tablet computers. The decision is significant because it represents the first substantive hearing in the European Union of the issue of inf...

IPKat: Ruling in Generics (t/a Mylan) v Yeda and Teva

Our cookies

Essential

Analytics

Social media & third party